Based on the results of this study, NP-based PD-1/PD-L1 blockade platforms increased IMT accuracy by a significant margin, reduced toxic off-target effects, and provided an extended immunological memory activity that may prevent tumor recurrence after initial eradication. Here, CD274 is linked to neoplasm.